Main > A1. CORP. INDEX. M-Mm > MacroCyclics Inc./P > 2005. 05.30.2005. (MDS Nordion)

---

MDS Nordion and Macrocyclics have entered a three-year research agreement to develop bifunctional chelates for use in molecular imaging and targeted therapeutics. The chelates will link a radioisotope to an antibody or other molecular targeting agent.


2005. 05.30.2005. (MDS Nordion)'s products
This section has no products